Asymmetric Synthesis of Tetrahydronaphthalenes in Water
FULL PAPER
pak AD-H (hexane/iPrOH=80:20, flow rate 1.0 mLminÀ1, l=210 nm),
tR (major)=13.3 min, tR (minor)=37.4 min; >99% ee; HRMS (ESI): m/
z calcd for C29H31N2O5: 487.2233 [M+H]; found 487.2232.
(m, 1H), 3.91 (t, J=8.0 Hz, 1H), 2.23–2.21 (m, 1H), 1.51–1.45 (m, 2H),
1.34 (t, J=7.2 Hz, 3H), 1.34–1.29 (m, 2H), 0.95 ppm (t, J=7.2 Hz, 3H);
13C NMR (100 MHz, CDCl3): d=170.3, 148.9, 134.7, 133.6, 129.6, 128.9,
128.4, 128.1, 127.8, 127.1, 117.7, 84.2, 77.2, 67.4, 62.0, 47.1, 38.4, 37.8, 30.4,
20.2, 14.2, 14.1 ppm; HPLC: Chiralpak AD-H (hexane/iPrOH=80:20,
flow rate 1.0 mLminÀ1, l=210 nm), tR (major)=9.3 min, tR (minor)=
38.1 min; >99% ee; HRMS (ESI): m/z calcd for C24H28N2O5Cl: 459.1687
[M+H]; found 459.1686.
(1R,3aS,4R,5S,9bR)-Benzyl
4-benzyl-5-(nitromethyl)-3-phenyl-
1,3,3a,4,5,9b-hexahydronaphthoACHTUNGTERNN[GUN 2,1-c]isoxazole-1-carboxylate (3i): The
title compound was prepared in 73% yield according to the typical pro-
cedure described above (the first step in 6 h, the second step in 4 h).
[a]2D4 =96.1 (c=1.0, CH2Cl2); 1H NMR (400 MHz, CDCl3): d=7.38–7.13
(m, 15H), 7.00–6.96 (m, 2H), 6.91–6.89 (m, 2H), 5.22–5.16 (m, 2H), 4.78
(m, 2H), 4.49 (d, J=6.8 Hz, 1H), 4.28 (t, J=7.2 Hz, 1H), 3.98–3.95 (m,
2H), 2.57–2.53 ppm (m, 2H); 13C NMR (100 MHz, CDCl3): d=169.8,
149.6, 138.3, 135.0, 134.6, 133.8, 129.7, 129.1, 128.9, 128.7, 128.65, 128.0,
127.8, 126.8, 123.2, 116.5, 83.7, 77.2, 67.6, 65.9, 47.5, 41.2, 37.7, 34.0 ppm;
(1R,3aS,4R,5S,9bR)-Ethyl 3-(4-bromophenyl)-5-(nitromethyl)-4-propyl-
1,3,3a,4,5,9b-hexahydronaphthoACHTUNTRGNEU[GN 2,1-c]isoxazole-1-carboxylate (3m): The
title compound was prepared in 67% yield according to the general pro-
cedure described above (the second step in 3 h). [a]2D4 =87.5 (c=0.9,
CH2Cl2); 1H NMR (400 MHz, CDCl3): d=7.42 (d, J=8.8 Hz, 2H), 7.3–
7.25 (m, 3H), 7.08–7.05 (m, 1H), 7.06 (d, J=8.8 Hz, 1H), 4.74 (dd, J=
6.0, 12.0 Hz, 1H), 4.67–4.64 (m, 1H), 4.43 (d, J=6.8 Hz, 1H), 4.28 (q, J=
7.2 Hz, 2H), 4.22 (t, J=7.2 Hz, 1H), 4.10–4.08 (m, 1H), 3.91 (t, J=
8.0 Hz, 1H), 2.23–2.18 (m, 1H), 1.65 (m, 1H), 1.52–1.46 (m, 2H), 1.34 (t,
J=7.2 Hz, 3H), 1.29–1.26 (m, 1H), 0.95 ppm (t, J=7.2 Hz, 3H);
13C NMR (100 MHz, CDCl3): d=170.3, 149.5, 134.7, 133.6, 131.8, 129.6,
128.2, 127.8, 127.0, 117.9, 115.8, 84.2, 77.2, 67.3, 62.0, 47.1, 38.5, 37.9, 30.5,
20.2, 14.2, 14.1 ppm; HPLC: Chiralpak AD-H (hexane/iPrOH=80:20,
flow rate 1.0 mLminÀ1, l=210 nm), tR (major)=8.7 min, tR (minor)=
34.0 min; >99% ee; HRMS (ESI): m/z calcd for C24H28N2O5Br: 504.3846
[M+H]; found 504.3848.
HPLC: Chiralcel OD-H (hexane/iPrOH=80:20, flow rate 1.0 mLminÀ1
,
l=210 nm), tR (major)=20.9 min, tR (minor)=28.3 min; >99% ee;
HRMS (ESI): m/z calcd for C33H31N2O5: 435.2233 [M+H]; found
535.2237.
(1R,3aS,4R,5S,9bR)-Benzyl
phenyl-1,3,3a,4,5,9b-hexahydronaphthoACHTUNGTRENNUNG
4-[2-(benzyloxy)ethyl]-5-(nitromethyl)-3-
[2,1-c]isoxazole-1-carboxylate
(3j): The title compound was prepared in 62% yield according to the typ-
ical procedure described above (the first step in 10 h, the second step in
10 h). [a]2D4 =50.7 (c=1.3, CH2Cl2); 1H NMR (400 MHz, CDCl3): d=
7.39–7.30 (m, 10H), 7.26–7.13 (m, 7H), 7.08–7.01 (m, 2H), 5.23 (s, 2H),
4.79 (dd, J=5.2, 12.0 Hz, 1H), 4.70–4.68 (m, 1H), 4.56–4.47 (m, 3H),
4.24 (t, J=7.2 Hz, 1H), 4.16–4.14 (m, 1H), 4.04 (t, J=8.0 Hz, 1H), 3.65–
3.63 (m, 2H), 2.46–2.43 (m, 1H), 1.98–1.84 (m, 1H), 1.66–1.64 ppm (m,
1H); 13C NMR (100 MHz, CDCl3): d=170.1, 150.1, 138.1, 135.0, 134.8,
133.6, 129.7, 128.9, 128.7, 128.5, 128.0, 127.8, 127.73, 127.71, 127.0, 123.2,
116.2, 84.0, 77.6, 73.2, 68.2, 67.6, 67.2, 47.2, 38.8, 36.4, 28.8 ppm; HPLC:
(1R,3aS,4R,5S,9bR)-Ethyl
3-benzyl-5-(nitromethyl)-4-propyl-
1,3,3a,4,5,9b-hexahydronaphthoACHTUNGTERNN[GUN 2,1-c]isoxazole-1-carboxylate (3n): The
title compound was prepared in 48% yield according to the general pro-
cedure described above (the second step in 24 h). [a]2D4 =À4.6 (c=0.8,
CH2Cl2); 1H NMR (400 MHz, CDCl3): d=7.42 (d, J=6.8 Hz, 2H), 7.36–
7.21 (m, 6H), 6.98 (d, J=7.6 Hz, 1H), 4.61 (m, 1H), 4.52 (dd, J=6.4,
12.0 Hz, 1H), 4.37–4.12 (m, 5H), 4.02–4.00 (m, 2H), 3.24 (t, J=7.2 Hz,
1H), 1.85 (m, 1H), 1.33 (t, J=7.2 Hz, 3H), 1.36–1.30 (m, 3H), 0.93–0.90
(m, 1H), 0.85 ppm (t, J=7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3): d=
171.4, 136.9, 134.7, 134.3, 129.7, 129.2, 128.4, 127.8, 127.6, 127.5, 126.3,
83.8, 77.2, 66.2, 61.8, 61.6, 48.3, 37.9, 29.9, 20.2, 14.2, 14.1 ppm; HPLC:
Chiralpak AD-H (hexane/iPrOH=80:20, flow rate 1.0 mLminÀ1
, l=
210 nm), tR (major)=17.4 min, tR (minor)=29.7 min; >99% ee; HRMS
(ESI): m/z calcd for C35H35N2O6: 579.2495 [M+H]; found 579.2498.
General procedure for the tandem reactions with different hydroxyla-
mines: Valeraldehyde (2a, 0.6 mmol, 3.0 equiv) was added to a suspen-
sion of catalyst I (2 mol%), benzoic acid (20 mol%), and nitroolefin ac-
rylate 1a (0.2 mmol, 1.0 equiv) in water (1.0 mL) at room temperature.
After 5 h, the nitroolefin 1a had been consumed, whereupon the requi-
site hydroxylamine (4-Me-C6H4NHOH, 4-Cl-C6H4NHOH, 4-Br-
C6H4NHOH, or BnNHOH) (0.8 mmol, 4.0 equiv) was added and the re-
sulting mixture was stirred for 3–24 h. When the reaction was complete
(monitoring by TLC and NMR analysis of aliquots taken directly from
the solution), the mixture was extracted with CH2Cl2 (2ꢁ5 mL). The
combined organic layers were washed repeatedly with brine and dried
over Na2SO4. The solvent was removed under reduced pressure and the
residue was subjected to flash chromatography on silica gel (EtOAc/
hexane, 1:20–1:12) to afford the product.
Chiralpak AD-H (hexane/iPrOH=80:20, flow rate 1.0 mLminÀ1
, l=
210 nm), tR (major)=5.7 min, tR (minor)=9.3 min; >99% ee; HRMS
(ESI): m/z calcd for C25H31N2O5: 439.2233 [M+H]; found 439.2233.
General procedure for the synthesis of 3o for X-ray analysis: Propional
(2b, 0.6 mmol, 3.0 equiv) was added to
a suspension of catalyst I
(2 mol%), benzoic acid (20 mol%), and nitroolefin acrylate 1c
(0.2 mmol, 1.0 equiv) in water (1.0 mL) at room temperature. After 5 h,
the nitroolefin 1c had been consumed, whereupon 4-chloro-N-hydroxy-
phenylamine (0.8 mmol, 4.0 equiv) was added and the resulting mixture
was stirred for 4 h. When the reaction was complete (monitoring by TLC
and NMR analysis of aliquots taken directly from the solution), the mix-
ture was extracted with CH2Cl2 (2ꢁ5 mL). The combined organic layers
were washed three times with brine, dried over Na2SO4, and the solvent
was removed under reduced pressure. The residue was subjected to flash
chromatography on silica gel to afford 3o in 61% yield (EtOAc/hexane,
(1R,3aS,4R,5S,9bR)-Ethyl
5-(nitromethyl)-4-propyl-3-p-tolyl-
1,3,3a,4,5,9b-hexahydronaphthoACHTUNGTERNN[GUN 2,1-c]isoxazole-1-carboxylate (3k): The
title compound was prepared in 74% yield according to the general pro-
cedure described above (the second step in 3 h). [a]2D4 =74.0 (c=1.0,
CH2Cl2); 1H NMR (400 MHz, CDCl3): d=7.28–7.24 (m, 3H), 7.15–7.07
(m, 5H), 4.76 (dd, J=5.6, 12.0 Hz, 1H), 4.66–4.63 (m, 1H), 4.41 (d, J=
7.2 Hz, 1H), 4.29 (q, J=7.2 Hz, 2H), 4.23 (t, J=7.2 Hz, 1H), 4.12 (m,
1H), 3.88 (t, J=8.0 Hz, 1H), 2.33 (s, 3H), 2.18–2.16 (m, 1H), 1.51–1.42
(m, 2H), 1.36 (t, J=7.2 Hz, 3H), 1.29–1.22 (m, 2H), 0.96 ppm (t, J=
7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3): d=170.5, 147.7, 134.8, 134.0,
133.3, 129.7, 129.5, 128.0, 127.6, 127.0, 117.2, 84.0, 77.5, 67.5, 61.9, 47.0,
38.6, 37.7, 30.4, 20.7, 20.2, 14.2, 14.1 ppm; HPLC: Chiralpak AD-H
(hexane/iPrOH=80:20, flow rate 1.0 mLminÀ1, l=210 nm), tR (major)=
10.7 min, tR (minor)=30.2 min; >99% ee; HRMS (ESI): m/z calcd for
C25H31N2O5: 439.2233 [M+H]; found 439.2234.
1
1:20–1:10). [a]2D4 =86.5 (c=0.5, CH2Cl2); H NMR (400 MHz, CDCl3): d=
7.26 (d, J=8.8 Hz, 2H), 7.09 (d, J=8.8 Hz, 1H), 6.72 (s, 1H), 6.55 (s,
1H), 5.95 (s, 2H), 4.70–4.61 (m, 2H), 4.36 (d, J=7.2 Hz, 1H), 4.28 (q, J=
7.2 Hz, 2H), 4.03 (t, J=7.2 Hz, 1H), 3.93–3.91 (m, 1H), 3.72 (t, J=
8.0 Hz, 1H), 2.33–2.28 (m, 1H), 1.32 (t, J=7.2 Hz, 3H), 1.10 ppm (d, J=
7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3): d=170.2, 148.8, 147.5, 147.4,
128.9, 128.5, 127.5, 126.7, 118.0, 109.2, 106.9, 101.4, 84.0, 77.6, 68.7, 62.1,
47.2, 40.2, 32.8, 14.2, 14.1 ppm; HPLC: Chiralpak AD-H (hexane/
iPrOH=80:20, flow rate 1.0 mLminÀ1, l=210 nm), tR (major)=16.0 min,
tR (minor)=35.5 min; >99% ee; HRMS (ESI): m/z calcd for
C23H23N2O7Cl: 475.1272 [M+H]; found 475.1275.
General procedure for the synthesis of a-hydroxy-g-amino acid deriva-
tives:
(1R,3aS,4R,5S,9bR)-Ethyl 3-(4-chlorophenyl)-5-(nitromethyl)-4-propyl-
1,3,3a,4,5,9b-hexahydronaphthoACHTUNTRGNEU[GN 2,1-c]isoxazole-1-carboxylate (3l): The
title compound was prepared in 64% yield according to the general pro-
cedure described above (the second step in 3 h). [a]2D4 =83.9 (c=1.0,
CH2Cl2); 1H NMR (400 MHz, CDCl3): d=7.29–7.23 (m, 5H), 7.13–7.07
(m, 3H), 4.74 (dd, J=6.0, 12.0 Hz, 1H), 4.67–4.64 (m, 1H), 4.43 (d, J=
7.2 Hz, 1H), 4.28 (q, J=7.2 Hz, 2H), 4.22 (t, J=7.2 Hz, 1H), 4.10–4.08
(R)-Ethyl 2-hydroxy-2-[(1R,2S,3R,4S)-4-(nitromethyl)-2-(phenylamino)-
3-propyl-1,2,3,4-tetrahydronaphthalen-1-yl]acetate (5): 10% Pd/C
(30 mg) was added to a solution of 3a (0.1 mmol) in methanol (5.0 mL)
at room temperature, which was maintained under an atmosphere of hy-
drogen by means of a balloon. After stirring for 2 h, the mixture was fil-
Chem. Eur. J. 2010, 16, 3842 – 3848
ꢀ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
3847